Refractory Cancer News and Research

RSS
Precision medicine for pediatric tumors can now be a reality, shows study

Precision medicine for pediatric tumors can now be a reality, shows study

First precision medicine trial in lung cancer expands to include more patients

First precision medicine trial in lung cancer expands to include more patients

Incorporating clinical genomic sequencing data into clinical management improves pediatric cancer treatment

Incorporating clinical genomic sequencing data into clinical management improves pediatric cancer treatment

Matched therapy and FoundationOne genomic profiling improve outcomes in patients with refractory cancer

Matched therapy and FoundationOne genomic profiling improve outcomes in patients with refractory cancer

Arisaph Pharmaceuticals receives STTR grants to develop cancer drug candidates

Arisaph Pharmaceuticals receives STTR grants to develop cancer drug candidates

Dr. Daniel D. Von Hoff named one of ASCO's 50 Oncology Luminaries

Dr. Daniel D. Von Hoff named one of ASCO's 50 Oncology Luminaries

Policy statement suggests ways to improve drug safety and efficacy in children

Policy statement suggests ways to improve drug safety and efficacy in children

New approaches needed for testing cancer drugs

New approaches needed for testing cancer drugs

XBiotech announces enrollment of first patient in Xilonix Phase III trial for treatment of cachexia

XBiotech announces enrollment of first patient in Xilonix Phase III trial for treatment of cachexia

Scripps Research receives $1.9 million NIH grant for prostate cancer study

Scripps Research receives $1.9 million NIH grant for prostate cancer study

GenSpera expands G-202 Phase I safety trial to CTRC at University of Texas Health Science Center

GenSpera expands G-202 Phase I safety trial to CTRC at University of Texas Health Science Center

New clinical research findings on oncology to be highlighted at ASCO 2010

New clinical research findings on oncology to be highlighted at ASCO 2010

Results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 to be presented at ASCO 2010

Results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 to be presented at ASCO 2010

Medarex starts phase 1b clinical trial with MDX-1106 for the treatment of cancer

Medarex starts phase 1b clinical trial with MDX-1106 for the treatment of cancer

Medarex announces preliminary data for investigational anti-PD-1 antibody

Medarex announces preliminary data for investigational anti-PD-1 antibody

Biotoxin from puffer fish may provide treatment for opioid withdrawal

Biotoxin from puffer fish may provide treatment for opioid withdrawal

Trial of a drug derived from the puffer fish for treatment of refractory cancer pain

Trial of a drug derived from the puffer fish for treatment of refractory cancer pain

Data on pre-clinical activity of satraplatin in prostate cancer to be released

Data on pre-clinical activity of satraplatin in prostate cancer to be released